The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis.
- DOI
- 10.3390/jcm15103613
- Published
- 2026 May 8
- Container
- Journal of clinical medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/jcm15103613,
title = {The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis.},
author = {Doğan T and Taş S and Güçlü Kantar T and Karahan İ and Gökçen Demiray A and Aykan MB and Yapar Taşköylü B and Özdemir M and Yaren A and Karadurmuş N and Gököz Doğu G},
year = {2026},
journal = {Journal of clinical medicine},
doi = {10.3390/jcm15103613},
url = {https://doi.org/10.3390/jcm15103613}
}RIS
TY - JOUR TI - The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis. AU - Doğan T AU - Taş S AU - Güçlü Kantar T AU - Karahan İ AU - Gökçen Demiray A AU - Aykan MB AU - Yapar Taşköylü B AU - Özdemir M AU - Yaren A AU - Karadurmuş N AU - Gököz Doğu G PY - 2026 JO - Journal of clinical medicine DO - 10.3390/jcm15103613 UR - https://doi.org/10.3390/jcm15103613 ER -
APA
T, D., S, T., T, G. K., İ, K., A, G. D., MB, A., B, Y. T., M, Ö., A, Y., N, K., & G, G. D. (2026). The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis.. Journal of clinical medicine. https://doi.org/10.3390/jcm15103613
Source records
- pubmed · retrieved 2026-09-25T16:42:00.829Z